Articles by Edward P. Acosta, PharmD

Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young Adults

Cressey, Tim R.; Hazra, Rohan; Wiznia, Andrew; More

The Pediatric Infectious Disease Journal. 35(12):1333-1335, December 2016.

Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults

Foca, Marc; Yogev, Ram; Wiznia, Andrew; More

The Pediatric Infectious Disease Journal. 35(9):e271-e274, September 2016.

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093

Viani, Rolando M.; Alvero, Carmelita; Fenton, Terry; More

The Pediatric Infectious Disease Journal. 34(11):1207-1213, November 2015.

STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS

King, Jennifer R.; Acosta, Edward P.; Yogev, Ram; More

The Pediatric Infectious Disease Journal. 28(2):159-161, February 2009.

Efficacy, Tolerability and Pharmacokinetics of Two Nelfinavir-Based Regimens in Human Immunodeficiency Virus-Infected Children and Adolescents: Pediatric AIDS Clinical Trials...

King, Jennifer R.; Nachman, Sharon; Yogev, Ram; More

The Pediatric Infectious Disease Journal. 24(10):880-885, October 2005.